On this week's episode of Industry Focus: Healthcare, host Shannon Jones and Motley Fool contributor Brian Feroldi catch listeners up on four companies we've talked about before: Abiomed (NASDAQ: ABMD), Inogen (NASDAQ: INGN), Guardant Health (NASDAQ: GH), and ShockWave Medical (NASDAQ: SWAV). Listen in to find out what each of these businesses does, and what updates they brought to the table this quarter -- from Abiomed's slow but steady recovery from the FDA debacle to ShockWave's shocking growth and more. Will Abiomed be able to move past its FDA letter troubles? Should investors worry about Inogen's sales snafu? Just how big can Guardant Health get? Is ShockWave worth its 65 times trailing sales multiple? Tune in to learn more!
To catch full episodes of all The Motley Fool's free podcasts, check out our podcast center. A full transcript follows the video.